Skip to main content
Clinical Trials/ISRCTN40579508
ISRCTN40579508
Terminated
未知

Quadriceps neuromuscular electrical stimultaion (NMES) as an adjunct to pulmonary rehabilitation in patients with COPD and quadriceps weakness - a randomised double-blind placebo-controlled trial

Royal Brompton & Harefield NHS Foundation Trust0 sites108 target enrollmentDecember 14, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic lower respiratory diseases
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Enrollment
108
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 14, 2017
End Date
March 31, 2022
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=40 years
  • 2\. Confirmed diagnosis of COPD according to GOLD guidelines
  • 3\. Referred for outpatient PR
  • 4\. Quadriceps muscle weakness defined as quadriceps maximum voluntary contraction (QMVC, kg) / Body Mass Index (BMI, kg/m2\) ratio \=1\.2
  • 5\. Able to provide written informed consent

Exclusion Criteria

  • 1\. Any condition that precludes providing informed consent e.g. cognitive impairment or inadequate English
  • 2\. Participation in an exclusively home\-based pulmonary rehabilitation programme
  • 3\. Predominant neuromuscular or joint limitation to walking or cycling
  • 4\. Co\-existing progressive neurological or neuromuscular condition
  • 5\. Contraindication for unsupervised use of NMES including pregnancy, implanted cardiac pacemaker, skin abrasion, metallic lower limb prosthesis
  • 6\. Formal supervised pulmonary rehabilitation in the preceding six months
  • 7\. Unstable cardiac conditions including unstable angina, unstable congestive heart failure, severe aortic stenosis, suspected aortic aneurysm
  • 8\. Active or suspected thromboembolic disease including recent pulmonary embolism
  • 9\. An acute exacerbation requiring antibiotics within the preceding four weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials